Phase Genomics
WA - SeattleBiotechnology
Focus: Phase Genomics is a Seattle-based biotechnology company specializing in microbial genome identification and sequencing technologies. The company went public in 2015 and operates in the genomics and microbiology diagnostics space.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
6
Should You Work at Phase Genomics?
AI assessmentBest suited for infrastructure, data science, or bioinformatics professionals betting on diagnostic/genomics platform value; lower transparency on clinical/commercial progress creates career risk.
Why Work Here
- Early-stage public company (founded 2015) with specialized focus on microbial genomics—a high-growth diagnostic market with structural tailwinds
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Phase Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.